145 related articles for article (PubMed ID: 38597902)
1. Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus.
Azuma N; Natsuaki M; Hashimoto N; Abe T; Ueda S; Ohno Y; Jinnin M; Matsui K
Mod Rheumatol Case Rep; 2024 Apr; ():. PubMed ID: 38597902
[TBL] [Abstract][Full Text] [Related]
2. Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review.
Khan MA; Khan FH; Khan HB; Saadeh C; Davey N
Cureus; 2023 May; 15(5):e39553. PubMed ID: 37378095
[TBL] [Abstract][Full Text] [Related]
3. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
4. Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
Carter LM; Wigston Z; Laws P; Vital EM
Br J Dermatol; 2023 Jul; 189(2):210-218. PubMed ID: 36944572
[TBL] [Abstract][Full Text] [Related]
5. Treatment With Voclosporin and Anifrolumab in a Patient With Lupus Nephritis and Refractory Discoid Lupus Erythematosus: A Case Report and Literature Review.
Karagenova R; Vodusek Z; Krimins R; Krieger A; Timlin H
Cureus; 2024 Mar; 16(3):e55321. PubMed ID: 38559540
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Scarring Alopecia in Discoid Variant of Chronic Cutaneous Lupus Erythematosus With Tacrolimus Lotion, 0.3.
Milam EC; Ramachandran S; Franks AG
JAMA Dermatol; 2015 Oct; 151(10):1113-6. PubMed ID: 26039539
[TBL] [Abstract][Full Text] [Related]
7. Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE.
Bao A; Petri MA; Fava A; Kang J
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38114267
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of BAFF and its receptors in discoid lupus erythematosus patients.
Chong BF; Tseng LC; Kim A; Miller RT; Yancey KB; Hosler GA
J Dermatol Sci; 2014 Mar; 73(3):216-24. PubMed ID: 24315762
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction.
Takezawa K; Ueda-Hayakawa I; Yamazaki F; Kambe N; Son Y; Okamoto H
Lupus; 2020 Jan; 29(1):79-82. PubMed ID: 31789124
[TBL] [Abstract][Full Text] [Related]
11. Tight correlation of 5-hydroxymethylcytosine expression with the scarring damage of discoid lupus erythematosus.
Li Q; Yang M; Chen K; Zhou S; Zhou S; Wu H
Lupus; 2022 Oct; 31(11):1306-1316. PubMed ID: 35817588
[TBL] [Abstract][Full Text] [Related]
12. Cicatricial alopecia: discoid lupus erythematosus.
Hordinsky M
Dermatol Ther; 2008; 21(4):245-8. PubMed ID: 18715293
[TBL] [Abstract][Full Text] [Related]
13. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.
Pons-Estel GJ; Aspey LD; Bao G; Pons-Estel BA; Wojdyla D; Saurit V; Alvarellos A; Caeiro F; Haye Salinas MJ; Sato EI; Soriano ER; Costallat LT; Neira O; Iglesias-Gamarra A; Reyes-Llerena G; Cardiel MH; Acevedo-Vásquez EM; Chacón-Díaz R; Drenkard C
Lupus; 2017 Jan; 26(1):73-83. PubMed ID: 27230554
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G; Helm LA; Clebak KT; Helm M
FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
[TBL] [Abstract][Full Text] [Related]
15. Pediatric discoid lupus erythematosus: Short report.
Hawat T; Ballouz S; Megarbane H; Haber R
Dermatol Ther; 2022 Jan; 35(1):e15170. PubMed ID: 34676640
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity.
Saghafi M; Hashemzadeh K; Sedighi S; Yazdanpanah MJ; Rezaieyazdi Z; Sahebari M; Esmaily H
J Cutan Med Surg; 2014 Oct; 18(5):316-9. PubMed ID: 25186992
[TBL] [Abstract][Full Text] [Related]
17. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.
Chong BF; Song J; Olsen NJ
Br J Dermatol; 2012 Jan; 166(1):29-35. PubMed ID: 21910708
[TBL] [Abstract][Full Text] [Related]
18. The natural history of pediatric-onset discoid lupus erythematosus.
Arkin LM; Ansell L; Rademaker A; Curran ML; Miller ML; Wagner A; Kenner-Bell BM; Chamlin SL; Mancini AJ; Klein-Gitelman M; Paller AS
J Am Acad Dermatol; 2015 Apr; 72(4):628-33. PubMed ID: 25648823
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
